ACTIVE

Life Science Strategy Consulting

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-39,4 k €-23,4 %over 1 year
Gross margin-29,5 k €-16,9 %over 1 year
Equity400 k €-9,0 %over 1 year

Identity

Source · BCE/KBO

Life Science Strategy Consulting is a Private limited company incorporated in 2014. Its main activity is: Public relations and communication activities. Its registered office is in Lasne.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0544.869.388
Incorporation
30/01/2014
Legal form
Private limited company
Registered office
Clos Trou du Renard 9
1380 Lasne · WallonieSee on map
Contributed capital
76 200,00 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 12 filings

Trend over 12 financial years

20252024202320222021
Income statement
Gross margin-29,5 k €-25,2 k €2,3 k €41,5 k €-26,1 k €
EBITDA-31,5 k €-25,4 k €2,3 k €41,2 k €-26,2 k €
Operating result-57,2 k €-51,7 k €-14,7 k €38,2 k €-33,9 k €
Net result-39,4 k €-31,9 k €1,7 k €29,1 k €-78,3 k €
Balance sheet
Equity400 k €439,4 k €471,3 k €469,6 k €440,5 k €
Total assets401,3 k €441,2 k €501,3 k €471,1 k €464,8 k €
Cash722,2 €5,3 k €6,7 k €47,5 k €99,7 k €
Debts1,3 k €1,8 k €30 k €1,5 k €24,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

Christian HOMSY

Director

Active

Ended mandates

Anne Caudron

Associate

Ended
Bastian HOMSY

Associate

Ended
Benjamin HOMSY

Associate

Ended
Christian HOMSY

Manager

Ended

Other companies at this address

Clos Trou du Renard 9 1380 Lasne
CompanyCBE no.
Gybe Therapeutics● Active
1040.390.623
NOOR● Active
1031.936.478

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/07/202604/07/202531/07/202407/08/202311/08/202221/07/2021
General meeting26/06/202627/06/202528/06/202430/06/202324/06/202225/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202526/06/202617/07/2026FrenchPDF
Micro model31/12/202427/06/202504/07/2025FrenchPDF
Micro model31/12/202328/06/202431/07/2024FrenchPDF
Micro model31/12/202230/06/202307/08/2023FrenchPDF
Micro model31/12/202124/06/202211/08/2022FrenchPDF
Micro model31/12/202025/06/202121/07/2021FrenchPDF
Micro model31/12/201926/06/202002/07/2020FrenchPDF
Micro model31/12/201828/06/201917/07/2019FrenchPDF
Micro model31/12/201729/06/201824/07/2018FrenchPDF
Abridged model31/12/201630/06/201725/07/2017FrenchPDF
Abridged model31/12/201524/06/201607/07/2016FrenchPDF
Abridged model31/12/201426/06/201527/06/2015FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

Christian HOMSY

Director

Active

Ended mandates

Anne Caudron

Associate

Ended
Bastian HOMSY

Associate

Ended
Benjamin HOMSY

Associate

Ended
Christian HOMSY

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates13/12/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DIVERS - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office27/06/2023
    SIEGE SOCIAL
    PDF
  • Other21/12/2015
    DIVERS
    PDF
  • Registered office18/12/2015
    SIEGE SOCIAL - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Other10/02/2014
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-39,4 k €↓
  2. 2024
    Annual accounts 2024-31,9 k €↓
  3. 2023
    Annual accounts 20231,7 k €↓
  4. 2023
    Name changeLife Science Strategy Consulting
  5. 2022
    Annual accounts 202229,1 k €↑
  6. 2021
    Annual accounts 2021-78,3 k €↓
  7. 2020
    Annual accounts 20208,7 k €↓
  8. 2019
    Annual accounts 2019371,1 k €↑
  9. 2018
    Annual accounts 2018150,9 k €↑
  10. 2017
    Annual accounts 2017-133,1 k €↓
  11. 2016
    Annual accounts 201625,4 k €↑
  12. 2015
    Annual accounts 2015573 €↓
  13. 2014
    Annual accounts 201419,1 k €
  14. 30/01/2014
    IncorporationPrivate limited company
  15. 2014
    Name changeLife Science Strategy Consulting en abrégé LSS Consulting